Literature DB >> 19021963

Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis.

Toshiaki Ohara1, Takahiro Oto, Kentaro Miyoshi, Hiroyuki Tao, Masaomi Yamane, Shinichi Toyooka, Megumi Okazaki, Hiroshi Date, Yoshifumi Sano.   

Abstract

We report a successful case of sirolimus treatment for chylous pleural and peritoneal effusions of lymphangioleiomyomatosis after lung transplantation. A 32-year-old woman underwent living donor lung transplantation. Persistent chylous pleural and peritoneal effusions were seen postoperatively. Pleurodesis by intrathoracic injection of OK-432, minomycin, and somatostatine analog failed to control chylous effusions. However, sirolimus treatment reduced the amount of chylous drainage and improved both chylous pleural and peritoneal effusions.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19021963     DOI： 10.1016/j.athoracsur.2008.07.062

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  15 in total

1.  A Case of Successful Therapy by Intrapleural Injection of Fibrin Glue for Chylothorax after Lung Transplantation for Lymphangioleiomyomatosis.

Authors:  Hisashi Oishi; Yasushi Hoshikawa; Tetsu Sado; Tatsuaki Watanabe; Akira Sakurada; Takashi Kondo; Yoshinori Okada
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-07-14       Impact factor: 1.520

2.  Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan.

Authors:  Hisashi Oishi; Tatsuaki Watanabe; Yasushi Matsuda; Masafumi Noda; Yutaka Ejima; Yoshikatsu Saiki; Kuniaki Seyama; Takashi Kondo; Yoshinori Okada
Journal:  Surg Today       Date:  2018-05-28       Impact factor: 2.549

3.  Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.

Authors:  Angelo M Taveira-DaSilva; Olanda Hathaway; Mario Stylianou; Joel Moss
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

Review 4.  Optimizing treatments for lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Expert Rev Respir Med       Date:  2012-06       Impact factor: 3.772

5.  Progress in the treatment of lymphangioleiomyomatosis: from bench to bedside.

Authors:  A M Taveira-DaSilva; J Moss
Journal:  Rev Port Pneumol       Date:  2012-04-04

6.  Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Authors:  Francis X McCormack; Nishant Gupta; Geraldine R Finlay; Lisa R Young; Angelo M Taveira-DaSilva; Connie G Glasgow; Wendy K Steagall; Simon R Johnson; Steven A Sahn; Jay H Ryu; Charlie Strange; Kuniaki Seyama; Eugene J Sullivan; Robert M Kotloff; Gregory P Downey; Jeffrey T Chapman; MeiLan K Han; Jeanine M D'Armiento; Yoshikazu Inoue; Elizabeth P Henske; John J Bissler; Thomas V Colby; Brent W Kinder; Kathryn A Wikenheiser-Brokamp; Kevin K Brown; Jean F Cordier; Cristopher Meyer; Vincent Cottin; Jan L Brozek; Karen Smith; Kevin C Wilson; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

7.  Management of refractory chylothorax in pulmonary lymphangioleiomyomatosis.

Authors:  Claire M Ellender; Trevor J Williams; Julian Gooi; Gregory I Snell; Helen M Whitford
Journal:  Respirol Case Rep       Date:  2015-05-18

8.  Successful management of bilateral refractory chylothorax after double lung transplantation for lymphangioleiomyomatosis.

Authors:  Mohammed Hussein; Yasser M Aljehani; Imran Nizami; Waleed Saleh
Journal:  Ann Thorac Med       Date:  2014-04       Impact factor: 2.219

9.  mTOR Inhibitors in Tuberous Sclerosis Complex.

Authors:  Paolo Curatolo; Romina Moavero
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

10.  Lung Transplantation for Lymphangioleiomyomatosis in Japan.

Authors:  Katsutoshi Ando; Yoshinori Okada; Miki Akiba; Takashi Kondo; Tomohiro Kawamura; Meinoshin Okumura; Fengshi Chen; Hiroshi Date; Takeshi Shiraishi; Akinori Iwasaki; Naoya Yamasaki; Takeshi Nagayasu; Masayuki Chida; Yoshikazu Inoue; Toyohiro Hirai; Kuniaki Seyama; Michiaki Mishima
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.